GlassScriptPrepare for your visit
Sonya S Ventour
Gastroenterology (Internal Medicine) · Baldwin, NY · NPI 1225016611
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$8,630.50
in general payments reported to CMS, 2019-2025 · $2,106 in 2025
The $2,106 reported for 2025 was more than what 80% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Who reported paying
General payments only, top 6 by amount.
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $2,098.60
- Redhill Biopharma INC. $1,202.34
- Abbvie INC. $1,091.20
- Madrigal Pharmaceuticals $735.96
- Takeda Pharmaceuticals U.S.A., INC. $602.98
- Ardelyx, INC. $432.91
Drugs and devices associated with these payments
Linzess Xifaxan Rezdiffra Creon Ibsrela Voquezna Zeposia Trulance Wegovy Viberzi Farxiga Entyvio
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sonya Ventour listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/237218/sonya-s-ventour